*Please note: Evidence from recently published studies has not yet been reviewed by the Task Force in terms of its potential effect on these recommendations.
2. Chesley LC: History and epidemiology of preeclampsia-eclampsia. Clin Obstet Gynecol 1984; 27: 801-820
3. Page EW, Christanson R: The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol 1976; 125: 740-746
4. Roberts JM, Redman CW: Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447-1451
5. National High Blood Pressure Education Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990; 163: 1691-1712
6. Wallenburg HCS: Detecting hypertensive disorders of pregnancy. In: Chalmers I, Enkin M, Kierse, ed: Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989; 382-402
7. Sibai BM, Caritis SN, Thom E, et al: Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329: 1213-1218
8. Beaufils M, Donsimoni R, Uzan S, et al: Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985; 840-842
9. Benigni A, Gregorini G, Frusca T, et al: Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357-362
10. Fisher KA, Luger A, Spargo BH, et al: Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine-Baltimore 1981; 60: 267-276
11. Rodriguez MH, Masaki DI, Mestman J, et al: Calcium/creatinine ration and microalbuminuria in the prediction of preeclampsia. Am J Obstet Gynecol 1988; 159: 1452-1455
12. Sibai BM: Pitfalls in diagnosis and management of preeclampsia. Am J Obstet Gynecol 1988; 159: 1-5
13. Fallis NE, Langford HG: Relation of second trimester blood pressure to toxemia of pregnancy in the primigravid patient. Am J Obstet Gynecol 1963; 87: 123-125
14. Moutquin JM, Rainville C, Giroux L, et al: A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 1985; 151: 191-196
15. CLASP Collaborative Group: CLASP: a randomized controlled trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619-629
16. Mathews DD, Shuttleworth TP, Hamilton EFB: Modern trends in management of non-albminuric hypertension in late pregnancy. Br Med J 1978; 2: 623-625
17. Gilstrap LC, Cunningham FG, Whalley PG: Management of pregnancy-induced hypertension in the nulliparous patient remote from term. Semin Perinatol 1978; 2: 73
18. Sibai BM, Gonzalez AR, Mabie WC, et al: A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987; 70: 323-327
19. Redman CW, Roberts JM: Management of pre-eclampsia. Lancet 1993; 341: 1451-1454
20. Cunningham FG, Lindheimer MD: Hypertension in pregnancy. N Engl J Med 1992; 326: 927-932
21. Chelsey LC: Eclampsia at the Margaret Hague Maternity Hospital. Bull Marg Hague Hosp 1953; 6: 2-11
22. American College of Obstetricians and Gynecologists. Standards for obstetric-gynecologic services, 6th ed. Washington, D.C.: American College of Obstetricians and Gynecologists, 1985: 17-18
23. The Society of Obstetricians and Gynaecologists of Canada: Guidelines for prenatal care in Canada - 1984. Bulletin 1984; 6(4): 1
24. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services: an Assessment of the Effectiveness of 169 Interventions. Williams & Wilkins, Baltimore, Md, 1989: 95-103
Link to Full Text of this review
Link to Structured Abstract of this review
Link to Summary Table of Recommendations of this review
Reprinted in modified format by the Canadian
Task Force on Preventive Health Care
with permission.
Original Copyright
© 1994 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified March 27, 1998.
